Avalon Globocare (FRA:2XJ0) ROCE % : -192.43% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Avalon Globocare ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Avalon Globocare's annualized ROCE % for the quarter that ended in Dec. 2023 was -192.43%.

Avalon Globocare ROCE % Historical Data

The historical data trend for Avalon Globocare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avalon Globocare ROCE % Chart

Avalon Globocare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-183.32

-154.88

-136.15

-77.19

-100.80

Avalon Globocare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-68.95	-49.90	-36.24	-17.61	-192.43

Avalon Globocare ROCE % Calculation

Avalon Globocare's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-14.081	/	( ( (18.646 - 3.38)	+	(18.875 - 6.202) )	/ 2 )
	=	-14.081	/	( (15.266	+	12.673)	/ 2 )
	=	-14.081	/	13.9695
	=	-100.80 %

Avalon Globocare's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-33.176	/	( ( (28.079 - 6.27)	+	(18.875 - 6.202) )	/ 2 )
	=	-33.176	/	( ( 21.809	+	12.673 )	/ 2 )
	=	-33.176	/	17.241
	=	-192.43 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Avalon Globocare (FRA:2XJ0) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Avalon Globocare ROCE % Related Terms

Thank you for viewing the detailed overview of Avalon Globocare's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avalon Globocare (FRA:2XJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » Avalon Globocare Corp (FRA:2XJ0) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALBT:USA

Address

4400 Route 9 South, Suite 3100, Freehold, NJ, USA, 07728

Website

https://www.avalon-globocare.com

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare (FRA:2XJ0) Headlines

No Headlines